Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jordi Picas"'
Autor:
Francisco Fernández-Campos, Francesc Navarro, Adrian Corrales, Jordi Picas, Eloy Pena, Jordi González, Francisco J. Otero-Espinar
Publikováno v:
Pharmaceutics, Vol 12, Iss 8, p 730 (2020)
A new cyclodextrin polypseudorotaxanes nail lacquer (Regenail®) containing biotin, methyl sulphonyl methane (MSM), and dimethylsilanediol salicylate was developed and evaluated in vitro and in vivo. The product was developed to improve nail status a
Externí odkaz:
https://doaj.org/article/0f796babaceb4631a66ec9a0153b7918
Autor:
Andre S Nell, Eva D'lom, Patrick Bouic, Montserrat Sabaté, Ramon Bosser, Jordi Picas, Mercè Amat, Gavin Churchyard, Pere-Joan Cardona
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89612 (2014)
To evaluate the safety, tolerability and immunogenicity of three different doses (5, 25 and 50 µg) of the novel antituberculous vaccine RUTI compared to placebo in subjects with latent tuberculosis infection.Double-blind, randomized, placebo-control
Externí odkaz:
https://doaj.org/article/80e8b01b80824ba6942419e1240dd216
Autor:
Antonio J. Zalacain‐Vicuña, Carlos Nieto, Jordi Picas, Helena Martínez, Rafael Bermejo, Adrián Corrales, Francisco Fernández Campos, Soledad Anguiano Igea, Francisco Javier Otero‐Espinar, Vicente García‐Patos Briones
Publikováno v:
Mycoses.
A new water-soluble formulation with ciclopirox has shown a higher penetration than other ciclopirox nail lacquers currently marketed, thus providing a higher concentration of ciclopirox into the nail.To evaluate the efficacy and safety of a new cicl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40f7437d2d76bd924ef7ffb2939fca68
https://doi.org/10.1111/myc.13543
https://doi.org/10.1111/myc.13543
Autor:
Jordi Picas Jufresa, Juan Ferrando Barberá, Agustín Buendía Eisman, Aurora Guerra-Tapia, Rafael Bermejo Rodríguez
Publikováno v:
Más dermatología. :5-18
espanolEstudio comparativo controlado con placebo realizado en tres grupos de 20 mujeres cada uno, posmenopausicas, de edades comprendidas entre los 50 y los 75 anos y con alopecia androgenica femenina (AAF) en estadio I-II de la escala de Ludwig. Lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ecf1b8ee9098305cdd2716720a41c8c
https://doi.org/10.5538/1887-5181.2018.30.5
https://doi.org/10.5538/1887-5181.2018.30.5
Autor:
Merce Amat, Patrick Bouic, Montserrat Sabaté, Gavin J. Churchyard, Ramon Bosser, Andre S. Nell, Pere-Joan Cardona, Eva D’lom, Jordi Picas
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 2, p e89612 (2014)
PLoS ONE, Vol 9, Iss 2, p e89612 (2014)
Objectives To evaluate the safety, tolerability and immunogenicity of three different doses (5, 25 and 50 µg) of the novel antituberculous vaccine RUTI compared to placebo in subjects with latent tuberculosis infection. Methods and Findings Double-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77484ee53ea25387c990a876f219853c
http://europepmc.org/articles/PMC3935928
http://europepmc.org/articles/PMC3935928